Table 1.
Serum copper and ceruloplasmin in controls and AD patients.
AD patients (n = 25) | Controls (n = 25) | test t | |
---|---|---|---|
Serum Copper (μmol/L) | 18 (6) | 13.2 (2.2) | p < 0.001 |
Ceruloplasmin (mg/dL) | 27.9 (6.2) | 26.5 (4.3) | p = 0.369 |
Copper bound to ceruloplasmin (μmol/L) | 13.1 (2.9) | 12.5 (0.4) | p = 0.369 |
Non-ceruloplsmin-copper (NCC) (μmol/L) | 4.9 (5.6) | 0.7 (1.9) | p = 0.001 |
Data are presented as means (SD). Significant at the p = 0.05 level.